NCT05536752: An ongoing trial by Smilebiotek Zhuhai Limited
This trial is ongoing. It must report results 1 month ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05536752 |
|---|---|
| Title | A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Efficacy of QA102 in Subjects With Dry Age-Related Macular Degeneration (AMD) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 22, 2022 |
| Completion date | Nov. 12, 2024 |
| Required reporting date | Nov. 12, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |